slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 67,561-67,590
Pages 3,679
Rows per page 30
Component
67,561-67,590 of 110,355
09
The chart compares quarterly container volumes (FEU) between 2021 and 2022, with a specific callout for the 10.6% growth in Q3.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 1 hit
19
Matson | Results Presentation Deck | 20 slidesMatson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 1 hit
20
Includes two separate tables for different time periods.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 1 hit
12
Includes specific callouts for 'Expenses not added back' for both periods.Membership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
17
Includes a bar chart showing loan expiry profile with drawn vs undrawn amounts.Membership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
04
The slide uses a stylized wireframe human body to illustrate the systemic presence of iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
09
Source: Rahib et al, JAMA Net 2021Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
11
Source: Collisson et al, Nat Can Rev 2019Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
12
The diagram contrasts the state of T cell inhibition (left) with T cell activation (right) via therapeutic antibodies.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
13
Kaplan-Meier curve showing progression-free survival over 48 months.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
14
Source: Renouf at al, Nat Com 2022. Includes Kaplan-Meier curves (A, B), Forest plot (C), and stacked bar chart of response rates (D).Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
15
Source: Weber et al, Cell 2020Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
16
Data from Munshi et al, NEJM 2021.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
22
The slide uses a biological process diagram to explain the mechanism of action for iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Proposed SolutionLoop · Logic Chain1 hit
24
The diagram depicts a biological process flow involving iNKT cells, DCs, MDSCs, and inflammatory monocytes.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
27
The slide presents clinical efficacy metrics (ORR, SD, mOS) and safety profile for iNKT cell therapy.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
28
The data shows a clear trend where the combination of iNKT activator + Fc enhanced CTLA-4 + PD-1 (Group F) results in the lowest number of metastases.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
29
The slide uses a process flow diagram to show trial progression and a list-based structure for clinical endpoints.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
33
The slide uses a staircase diagram to represent dose escalation levels.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
34
The slide presents a patient cohort table and a specific case study (Patient 6) showing M-spike protein and plasma cell levels over time.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
35
The slide presents clinical trial safety data including a table of adverse events and dot plots for inflammatory markers.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
47
The diagram shows the interaction between tumor cell receptors and iNKT cell receptors, including the secretion of IL15.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
60
The slide uses a contrast-pairs framework to highlight the competitive advantage of the company's technology.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
64
The slide uses a 'Our World in Data' chart to provide context for the mortality rates listed on the left.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
66
The slide uses a combination of medical illustration and real-world clinical photography to explain the procedure.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
82
The slide depicts a mechanism of immune evasion via metabolic competition and immunosuppressive signaling.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
89
Scientific visualization of immune cell behavior in adipose tissue.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
90
Data from Lynch et al. Nature Immunology 2015 and Lynch et al. Immunity 2012.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
07
Includes stacked bar chart for historical growth, pie chart for loan composition, and table for credit quality metrics.Morgan Stanley | Fixed Income Presentation Deck | 11 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
05
Project Orange preliminary draft.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Problem & Complication1 hit